title: [Treatment of recurrent ovarian cancer].
authors.affiliation: Department of Medical Oncology, Hyogo Cancer Center.
authors.forename: Akihito
authors.initials: A
authors.lastname: Kitao
authors.forename: Koji
authors.initials: K
authors.lastname: Matsumoto
mesh_terms: D000970:Antineoplastic Agents; D000077216:Carcinoma, Ovarian Epithelial; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D009375:Neoplasms, Glandular and Epithelial / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000628:therapy*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D012086:Reoperation; D019772:Topotecan / Q000627:therapeutic use; D000093542:Gemcitabine
chemical_list: D000970:Antineoplastic Agents; C506643:liposomal doxorubicin; D003841:Deoxycytidine; D011092:Polyethylene Glycols; D005047:Etoposide; D019772:Topotecan; D004317:Doxorubicin; D000093542:Gemcitabine